Today: 15 May 2026

Powell Industries’ $400 Million Data Center Order Puts Its AI Power Boom to the Test

Powell Industries’ $400 Million Data Center Order Puts Its AI Power Boom to the Test

Powell Industries reported fiscal Q2 new orders surged 97% to $490 million, lifting backlog to a record $1.8 billion. Profit slipped 1% to $45.9 million, missing analyst forecasts along with revenue. The company disclosed a post-quarter data center order exceeding $400 million, its largest ever. Shares fell nearly 2% before recovering slightly after hours.
Firefly Aerospace Stock Jumps After Q1 Revenue Beat and Golden Dome Defense Deal

Firefly Aerospace Stock Jumps After Q1 Revenue Beat and Golden Dome Defense Deal

Firefly Aerospace shares jumped 10% in after-hours trading Monday after reporting record first-quarter revenue of $80.9 million, up 40% from the prior quarter. The company kept its 2026 revenue outlook and said its SciTec unit won a U.S. Space Force contract for the Space-Based Interceptor program. Firefly’s net loss widened to $96.7 million, but its adjusted loss beat analyst estimates.
Sterling Infrastructure Stock Jumps as Data-Center Work Drives Q1 Beat, 2026 Outlook Raise

Sterling Infrastructure Stock Jumps as Data-Center Work Drives Q1 Beat, 2026 Outlook Raise

Sterling Infrastructure shares jumped 19% in late trading Monday after first-quarter profit and revenue beat estimates and the company raised its 2026 outlook. Net income was $96 million on revenue of $825.7 million, with E-Infrastructure revenue up 174% to $597.7 million. Backlog reached $3.80 billion, up 78% from a year ago. Building Solutions adjusted operating income fell 42% amid continued housing market weakness.
Stock Market Today: Dow Sinks 557 Points as Oil Shock Tests Wall Street’s Record Run

Stock Market Today: Dow Sinks 557 Points as Oil Shock Tests Wall Street’s Record Run

U.S. stocks fell Monday, with the S&P 500 down 0.4% and the Dow losing 557 points, after oil prices surged and fighting resumed near the Strait of Hormuz. Brent crude jumped 5.8% to $114.44 a barrel after the UAE reported an Iranian attack. The U.S. military said it sank six boats targeting civilian ships in the area. FedEx and UPS shares dropped over 9% after Amazon announced new supply chain services.
5 May 2026
Pinterest Stock Surges After Q1 Earnings Beat as AI Ad Push Lifts Revenue Outlook

Pinterest Stock Surges After Q1 Earnings Beat as AI Ad Push Lifts Revenue Outlook

Pinterest shares jumped 15% to $24.06 in after-hours trading after first-quarter revenue beat estimates and the company issued a strong second-quarter outlook. Revenue rose 18% to $1.008 billion, with global monthly active users up 11% to 631 million. The quarter saw a net loss of $73.6 million, but adjusted earnings reached 27 cents per share, topping forecasts. Pinterest cited ongoing economic and regulatory risks in its outlook.
Gloo Closes Workday Partner Deal as AI Services Push Hits a Key Test

Gloo Closes Workday Partner Deal as AI Services Push Hits a Key Test

Gloo completed its acquisition of EnterpriseMarketdesk, expanding its Workday consulting and support services for nonprofits and mid-market clients. The deal includes issuing about 1.46 million Class A shares, with final terms undisclosed. Gloo shares fell 1.1% to $6.97 after the news. The company reported fiscal 2025 revenue of $94.7 million and raised 2026 guidance to $190 million.
Lunai Bioworks Stock: $20 Million Patent Deal Puts Nasdaq Fight in Focus

Lunai Bioworks Stock: $20 Million Patent Deal Puts Nasdaq Fight in Focus

Lunai Bioworks issued $20 million in Series B preferred stock to acquire Neurobridge IP Holdings’ CNS drug-delivery and neurotherapeutic patents, closing the deal May 1. The company said the transaction lifts its stockholders’ equity above Nasdaq’s $2.5 million listing minimum. Lunai shares traded at $0.3246 Monday, leaving its market value at $7.6 million. The acquired assets consist solely of patents, with no cash paid.
Cabaletta Bio Stock Jumps: Inside the $150 Million Bet on CABA’s Cell Therapy

Cabaletta Bio Stock Jumps: Inside the $150 Million Bet on CABA’s Cell Therapy

Cabaletta Bio shares surged 32% after the company reported early results from its cell-therapy trial and priced a $150 million stock offering with participation from Eli Lilly and others. Two of four pemphigus vulgaris patients showed clinical activity with rese-cel, its experimental CAR-T therapy. The company expects to fund operations into mid-2027. New data will be presented at the ASGCT meeting on May 14.
Union Pacific’s $85 Billion Norfolk Southern Merger Faces a New Walk-Away Test

Union Pacific’s $85 Billion Norfolk Southern Merger Faces a New Walk-Away Test

Union Pacific warned it could drop its $85 billion bid for Norfolk Southern if U.S. regulators require major line sales or trackage rights as merger conditions. The Surface Transportation Board is still reviewing whether the revised application is complete, with a May 8 deadline for comments. CSX and other rivals have stepped up opposition, citing reduced competition. Union Pacific may owe Norfolk Southern a $2.5 billion fee if it walks away.
Mirum Stock Jumps After Volixibat Trial Win Puts First PSC Itch Drug Within Reach

Mirum Stock Jumps After Volixibat Trial Win Puts First PSC Itch Drug Within Reach

Mirum Pharmaceuticals said its drug volixibat met the main goal in a 158-patient Phase 2b trial for primary sclerosing cholangitis, reducing itch scores more than placebo. Shares rose about 9% after the announcement. The company plans a pre-NDA meeting with the FDA this summer and aims to file for U.S. approval in the second half of 2026. No FDA-approved therapies currently exist for this rare liver disease.
Sangamo Stock Jumps Before Nasdaq Exit: Why SGMO Investors Are Watching May 5

Sangamo Stock Jumps Before Nasdaq Exit: Why SGMO Investors Are Watching May 5

Sangamo Therapeutics shares jumped about 33% Monday as the company prepared to move from Nasdaq to the OTCQB Venture Market following a delisting notice over its sub-$1 share price. Nasdaq is set to suspend trading in SGMO on May 5. Sangamo said it will appeal but expects trading to shift regardless. The company is seeking new funding and continues talks on partnerships and its Fabry disease gene therapy.
4 May 2026
Above Food Ingredients (ABVE) Stock Jumps as Delayed 20-F Filing Keeps Investors on Edge

Above Food Ingredients (ABVE) Stock Jumps as Delayed 20-F Filing Keeps Investors on Edge

Above Food Ingredients shares surged about 22% to $0.65 in heavy Nasdaq trading Monday, with volume topping 42 million shares. The rally came as the company’s fiscal 2025 annual report remained delayed due to an ongoing audit. Above Food last reported a net loss of $53.3 million and a working-capital deficit of $85.4 million. Peer food and ingredient stocks moved little by comparison.
Cenovus Energy Stock Climbs Before Q1 Results as CIBC Puts MEG Deal in Focus

Cenovus Energy Stock Climbs Before Q1 Results as CIBC Puts MEG Deal in Focus

Cenovus Energy shares climbed 2.9% to C$40.96 in Toronto after CIBC Capital Markets reaffirmed an outperformer rating and set a C$46 target ahead of first-quarter results. CIBC estimated quarterly production at 962,000 barrels of oil equivalent per day and projected cash flow per share of C$1.63, above consensus. Cenovus will report results May 6, its first full quarter including former MEG Energy assets.
Celcuity Stock Jumps 16% as Gedatolisib Breast-Cancer Data Raise FDA Stakes

Celcuity Stock Jumps 16% as Gedatolisib Breast-Cancer Data Raise FDA Stakes

Celcuity Inc. shares rose nearly 16% Monday after reporting its breast cancer drug gedatolisib met the main goal in a late-stage trial for patients with PIK3CA-mutant tumors. The company plans to submit the new data to the FDA as a supplemental application. Celcuity traded at $145.54, up $19.89, with a market value near $6.9 billion. A July 17 FDA decision on gedatolisib for a related use remains pending.
DoorDash Just Opened Kroger Delivery to SNAP Cards at 2,700 Stores

DoorDash Just Opened Kroger Delivery to SNAP Cards at 2,700 Stores

National Grid’s London shares did not trade Monday due to the UK bank holiday, while its New York ADR fell $1.12 to $87.36. Investors await May 14 full-year results after the company warned of a roughly 1 pence EPS hit from U.S. regulatory refunds and storm costs. U.S. peers Eversource and Avangrid are seeking higher allowed returns from FERC following a March ruling that cut rates and ordered $1.5 billion in refunds.
1 38 39 40 41 42 1,936

Stock Market Today

  • Cerebras CEO Details AI Chip Innovation Amid $5.5 Billion IPO
    May 14, 2026, 6:34 PM EDT. Cerebras Systems raised $5.5 billion in its IPO, with shares priced at $185 and opening indications near $400, CEO Andrew highlights. The company introduced an AI chip the size of a dinner plate, 58 times larger than prior chips and 15 times faster than competitors, advancing AI processing speed. Andrew emphasized Cerebras' unique ability to build these large chips, stating industry attempts over 70 years have failed until now. As AI demand surges, the firm sees the industry moving toward their large-chip design as a standard, noting multi-chip setups as intermediate steps. Cerebras aims to meet growing AI workload needs with their pioneering chip technology.

Latest articles

Unusual Machines Stock Jumps As Q1 Revenue Nearly Quadruples And Drone Supply Bet Widens

Unusual Machines Stock Jumps As Q1 Revenue Nearly Quadruples And Drone Supply Bet Widens

15 May 2026
Unusual Machines reported first-quarter revenue of $8.1 million, up 296% from a year earlier, and net income of $10.3 million driven by investment gains despite an operating loss. Shares rose 12.8% to $16.93 after the results. The company raised $150 million in equity and agreed to buy battery maker DroneNX for up to $52 million. Headcount rose to over 190 as of Thursday.
Microsoft Stock Rises As AI Trade Reignites: Why MSFT Shares Moved Today

Microsoft Stock Rises As AI Trade Reignites: Why MSFT Shares Moved Today

15 May 2026
Microsoft shares rose 1.04% to $409.43 on Thursday as investors favored large tech stocks amid record highs for the S&P 500 and Nasdaq. Microsoft reported March-quarter revenue up 18% to $82.9 billion, with Azure and cloud services up 40%. The company expects $190 billion in capital expenditures this year, well above analyst estimates. Microsoft is also exploring AI startup deals as it reassesses its reliance on OpenAI.
United States Antimony Stock Falls After $11.3 Million Loss as Defense Contract Ramp Awaits

United States Antimony Stock Falls After $11.3 Million Loss as Defense Contract Ramp Awaits

15 May 2026
United States Antimony posted a first-quarter net loss of $11.3 million, or 8 cents a share, on $6.8 million in revenue, down from a $546,524 profit a year earlier. Shares fell about 4% to $9.57 in late trading. The company completed initial deliveries under a $245 million Defense Logistics Agency contract but did not recognize revenue from it in the quarter. Gross profit dropped to $1.1 million from $2.4 million.
Apple Stock Falls After $300 Test: Why AAPL’s OpenAI Risk Is Back

Apple Stock Falls After $300 Test: Why AAPL’s OpenAI Risk Is Back

15 May 2026
Apple shares fell 0.2% to $298.21 Thursday after news that OpenAI is considering legal action over a strained partnership, Reuters reported. The drop came despite Apple hitting $300.45 intraday and posting record quarterly revenue of $111.2 billion. The S&P 500 and Nasdaq closed at records. Apple did not comment on the OpenAI report.
Go toTop